1.Susceptibility of Laboratory Rodents to Trichinella papuae.
Lakkhana SADAOW ; Pewpan M INTAPAN ; Thidarut BOONMARS ; Nimit MORAKOTE ; Wanchai MALEEWONG
The Korean Journal of Parasitology 2013;51(6):629-632
Members of the genus Trichinella are small nematodes that can infect a wide range of animal hosts. However, their infectivity varies depending on the parasite and host species combination. In this study, we examined the susceptibility of 4 species of laboratory rodents, i.e., mice, rats, hamsters, and gerbils to Trichinella papuae, an emerging non-encapsulated Trichinella species. Trichinella spiralis and Trichinella pseudospiralis were also included in this study for comparison. Fifteen animals of each rodent species were infected orally with 100 muscle larvae of each Trichinella species. Intestinal worm burden was determined at day 6 and 10 post-inoculation (PI). The numbers of muscle larvae were examined at day 45 PI. The reproductive capacity index (RCI) of the 3 Trichinella species in different rodent hosts was determined. By day 6 PI, 33.2-69.6% of the inoculated larvae of the 3 Trichinella species became adult worms in the small intestines of the host animals. However, in rats, more than 96% of adult worms of all 3 Trichinella species were expelled from the gut by day 10 PI. In gerbils, only 4.8-18.1% of adult worms were expelled by day 10 PI. In accordance with the intestinal worm burden and the persistence of adults, the RCI was the highest in gerbils with values of 241.5+/-41.0 for T. papuae, 432.6+/-48 for T. pseudospiralis, and 528.6+/-20.6 for T. spiralis. Hamsters ranked second and mice ranked third in susceptibility in terms of the RCI, Rats yielded the lowest parasite RCI for all 3 Trichinella species. Gerbils may be an alternative laboratory animal for isolation and maintenance of Trichinella spp.
Animals
;
*Animals, Laboratory
;
Cricetinae
;
*Disease Susceptibility
;
Gerbillinae
;
Intestines/parasitology
;
Male
;
Mice
;
Muscles/parasitology
;
Parasite Load
;
Rats
;
Rodent Diseases/*parasitology/pathology
;
Trichinella/*growth & development
;
Trichinellosis/parasitology/pathology/*veterinary
2.An Indigenous Case of Intestinal Capillariasis with Protein-Losing Enteropathy in Korea.
Woon Tae JUNG ; Hyun Jin KIM ; Hyun Ju MIN ; Chang Yoon HA ; Hong Jun KIM ; Gyung Hyuck KO ; Byoung Kuk NA ; Woon Mok SOHN
The Korean Journal of Parasitology 2012;50(4):333-337
We encountered an indigenous case of intestinal capillariasis with protein-losing enteropathy in the Republic of Korea. A 37-year-old man, residing in Sacheon-si, Gyeongsangnam-do, admitted to the Gyeongsang National University Hospital (GNUH) due to long-lasting diarrhea, abdominal pain, anasarca, and weight loss. He recalled that he frequently ate raw fish, especially the common blackish goby (Acanthogobius flavimanus) and has never been abroad. Under the suspicion of protein-losing enteropathy, he received various kinds of medical examinations, and was diagnosed as intestinal capillariasis based on characteristic sectional findings of nematode worms in the biopsied small intestine. Adults, juvenile worms, and eggs were also detected in the diarrheic stools collected before and after medication. The clinical symptoms became much better after treatment with albendazole 400 mg daily for 3 days, and all findings were in normal range in laboratory examinations performed after 1 month. The present study is the 6th Korean case of intestinal capillariasis and the 3rd indigenous one in the Republic of Korea.
Adult
;
Albendazole/administration & dosage
;
Animals
;
Anthelmintics/administration & dosage
;
Biopsy
;
Capillaria/cytology/drug effects/*isolation & purification
;
Diarrhea
;
Enoplida Infections/drug therapy/parasitology/*pathology
;
Feces/parasitology
;
Female
;
Helminthiasis/drug therapy/parasitology/*pathology
;
Humans
;
Intestinal Diseases, Parasitic/drug therapy/parasitology/*pathology
;
Intestines/parasitology/pathology
;
Male
;
Protein-Losing Enteropathies/drug therapy/parasitology/*pathology
;
Republic of Korea
;
Treatment Outcome
3.Alteration of Cytokine Production during Visceral Larva Migrans by Toxascaris leonina in Mice.
Shin Ae KANG ; Mi Kyung PARK ; Min Kyoung CHO ; Hak Sun YU
The Korean Journal of Parasitology 2013;51(5):583-588
To determine alteration of immune responses during visceral larva migrans (VLM) caused by Toxascaris leonina at several time points, we experimentally infected mice with embryonated eggs of T. leonina and measured T-helper (Th) cell-related serial cytokine production after infection. At day 5 post infection (PI), most larvae were detected from the lungs, spleen, intestine, and muscle. Expression of thymic stromal lymphopoietin (TSLP) and CCL11 (eotaxin) showed a significant increase in most infected organs, except the intestine. However, expression of the CXCL1 (Gro-alpha) gene was most highly enhanced in the intestine at day 14 PI. Th1-related cytokine secretion of splenocytes showed increases at day 28 PI, and the level showed a decrease at day 42 PI. Th2-related cytokine secretion of splenocytes also showed an increase after infection; in particular, IL-5 level showed a significant increase at day 14 PI, and the level showed a decrease at day 28 PI. However, levels of Th17-related cytokines, IL-6 and IL-17A, showed gradual increases until day 42 PI. In conclusion, Th1, Th2, and Th17-related cytokine production might be important in immune responses against T. leonina VLM in experimental mice.
Animals
;
Brain/parasitology
;
Cytokines/*metabolism
;
Female
;
Gene Expression Regulation
;
Heart/parasitology
;
Interleukins/*metabolism
;
Intestines/parasitology
;
Larva Migrans, Visceral/*immunology/parasitology
;
Liver/parasitology
;
Lung/parasitology/pathology
;
Mice
;
Mice, Inbred C57BL
;
Muscles/parasitology
;
Spleen/parasitology
;
Th1 Cells/immunology
;
Th17 Cells/immunology
;
Th2 Cells/immunology
;
Toxascaris/*immunology
4.Effect of Ketoconazole, a Cytochrome P450 Inhibitor, on the Efficacy of Quinine and Halofantrine against Schistosoma mansoni in Mice.
Sayed Hassan SEIF EL-DIN ; Abdel Nasser Abdel Aal SABRA ; Olfat Ali HAMMAM ; Naglaa Mohamed EL-LAKKANY
The Korean Journal of Parasitology 2013;51(2):165-175
The fear that schistosomes will become resistant to praziquantel (PZQ) motivates the search for alternatives to treat schistosomiasis. The antimalarials quinine (QN) and halofantrine (HF) possess moderate antischistosomal properties. The major metabolic pathway of QN and HF is through cytochrome P450 (CYP) 3A4. Accordingly, this study investigates the effects of CYP3A4 inhibitor, ketoconazole (KTZ), on the antischistosomal potential of these quinolines against Schistosoma mansoni infection by evaluating parasitological, histopathological, and biochemical parameters. Mice were classified into 7 groups: uninfected untreated (I), infected untreated (II), infected treated orally with PZQ (1,000 mg/kg) (III), QN (400 mg/kg) (IV), KTZ (10 mg/kg)+QN as group IV (V), HF (400 mg/kg) (VI), and KTZ (as group V)+HF (as group VI) (VII). KTZ plus QN or HF produced more inhibition (P<0.05) in hepatic CYP450 (85.7% and 83.8%) and CYT b5 (75.5% and 73.5%) activities, respectively, than in groups treated with QN or HF alone. This was accompanied with more reduction in female (89.0% and 79.3%), total worms (81.4% and 70.3%), and eggs burden (hepatic; 83.8%, 66.0% and intestinal; 68%, 64.5%), respectively, and encountering the granulomatous reaction to parasite eggs trapped in the liver. QN and HF significantly (P<0.05) elevated malondialdehyde levels when used alone or with KTZ. Meanwhile, KTZ plus QN or HF restored serum levels of ALT, albumin, and reduced hepatic glutathione (KTZ+HF) to their control values. KTZ enhanced the therapeutic antischistosomal potential of QN and HF over each drug alone. Moreover, the effect of KTZ+QN was more evident than KTZ+HF.
Animals
;
Anthelmintics/*administration & dosage
;
Disease Models, Animal
;
Drug Synergism
;
Female
;
Humans
;
Intestines/parasitology
;
Ketoconazole/*administration & dosage
;
Liver/parasitology/pathology
;
Male
;
Mice
;
Parasite Load
;
Phenanthrenes/*administration & dosage
;
Quinine/*administration & dosage
;
Schistosoma mansoni/isolation & purification
;
Schistosomiasis mansoni/*drug therapy/pathology
;
Treatment Outcome